Legacy of mistrust among African Americans persists on cancer treatment
Mistrust toward breast cancer treatment and the health care system at large were expressed by African Americans who participated in Chicago focus groups, suggests new research led by an expert on the health of vulnerable populations at the Brown School at Washington University in St. Louis.
Study uncovers inherited genetic susceptibility across 12 cancer types
In a new analysis, researchers at the School of Medicine have shed light on the hereditary elements across 12 cancer types — showing a surprising inherited component to stomach cancer and providing some needed clarity on the consequences of certain types of mutations in well-known breast cancer susceptibility genes BRCA1 and BRCA2.
Study uncovers hard-to-detect cancer mutations
New research, led by Li Ding, PhD, shows that current genome analysis approaches systematically miss detecting a certain type of complex mutation in cancer patients’ tumors. A significant percentage of these complex mutations are found in well-known cancer genes that could be targeted by existing drugs, potentially expanding the number of cancer patients who may benefit.
Vitamin D relieves joint, muscle pain for breast cancer patients
High-dose vitamin D relieves joint and muscle pain for many breast cancer patients taking estrogen-lowering drugs, according to a new study from Washington University School of Medicine in St. Louis.
Pappu joins new St. Jude, Scripps Research Institute initiative
Rohit Pappu, PhD, the Edwin H. Murty Professor of Engineering at Washington University’s School of Engineering & Applied Science, will help spearhead the newly formed Human Dark Proteome Initiative, launched Nov. 9 by St. Jude Children’s Research Hospital and The Scripps Research Institute.
Flipping the switch to better see cancer cells at depths
A team of engineers, led by Washington University’s Lihong Wang and postdoctoral researcher Junjie Yao, found that by genetically modifying glioblastoma cancer cells to express BphP1 protein, derived from a bacterium commonly found in soil and water, they could clearly see tiny amounts of live cancer cells as deep as 1 centimeter in tissue using photoacoustic tomography.
Cells’ lack of glucose dulls immune system’s ability to fight cancers
Cancers have many strategies for avoiding attacks from the immune system. But the more scientists are able to understand about them, the more effectively they will be able to use the immune system to fight cancer. To that end, researchers at Washington University School of Medicine in St. Louis have identified a new strategy.
Personalized melanoma vaccines marshal powerful immune response
Personalized melanoma vaccines can be used to marshal a powerful immune response against unique mutations in patients’ tumors, according to early data in a first-in-people clinical trial at Washington University School of Medicine in St. Louis. The research is a boost to cancer immunotherapy, a treatment strategy that unleashes the immune system to seek out and destroy cancer.
Study sheds new light on asthma, COPD
In cells lining the airway, high levels of certain proteins have long been linked with the overproduction of mucus characteristic of diseases like asthma and COPD. New research from the School of Medicine provides clues to potentially counteract inappropriate mucus production.
Innovative light therapy reaches deep tumors
Researchers led by Samuel Achilefu, PhD, at the School of Medicine have devised a way to apply light-based therapy to deep tissues never before accessible. Instead of shining an outside light, they delivered light directly to tumor cells, along with a photosensitive source of free radicals that can be activated by the light to destroy cancer.
View More Stories